Sociedad Americana de Hirudoterapia

Diabetic foot ulcer with osteomyelitis, successfully treated with the holistic approach of multiple ayurvedic treatment modalities - A case report

Bopparathi S, K V NR (2023) · International Journal of Surgery Case Reports · n=1

Detalle de evidencia de RCTReferencia del ensayo
GRADE muy bajaEvidencia insuficienteCondición: Venous Leg Ulcer →
Tamaño de muestra de este ensayo en comparación con otros ensayos de Venous Leg UlcerBopparathi S 20231Begum S 20251
Este ensayo (destacado) por tamaño de muestra junto a otros ensayos indexados de Venous Leg Ulcer. Los ensayos más grandes generalmente tienen mayor peso estadístico.

Perfil del estudio

Diseño
single-patient Ayurveda case report of multimodal Ayurvedic treatment including medicinal leech therapy (MLT) for diabetic foot ulcer with osteomyelitis (National Institute of Ayurveda, Jaipur, Rajasthan, India)
Tamaño de la muestra (n)
1
Intervención
Multimodal Ayurvedic regimen including surgical debridement, medicinal leech therapy (MLT), irrigation with Triphala decoction, jatyadi tail dressings, oral Ayurvedic antidiabetic medications, and herbo-mineral antimicrobial preparations in a 48-year-old female with uncontrolled type 2 diabetes presenting with gangrenous deep circular plantar ulcer (3×4 cm) with first-webspace involvement and X-ray-confirmed osteomyelitis after 3 months of failed conventional antibiotic and antidiabetic therapy
Comparador
Not applicable - single-patient case report; pre/post within-subject timeline with prior failed conventional therapy as historical control
Punto final primario
Wound healing, prevention of amputation, control of blood sugar, and resolution of osteomyelitis through holistic Ayurvedic management
Resultado primario
Holistic Ayurvedic approach including medicinal leech therapy successfully treated diabetic foot ulcer with osteomyelitis in a patient previously recommended for toe amputation; wound healing achieved without amputation; authors conclude that holistic Ayurvedic modalities are effective and safe in treating DFUs with osteomyelitis and in preventing amputation
Duración del seguimiento
post-multimodal-treatment wound-healing period

Hallazgos clave

  • Documents multimodal Ayurvedic limb-salvage approach including medicinal leech therapy in DFU with osteomyelitis
  • Patient avoided recommended toe amputation - clinically meaningful patient-centered outcome
  • Adds the National Institute of Ayurveda perspective to the global leech-therapy diabetic foot ulcer literature
  • Documents that medicinal leech therapy can be integrated with conventional surgical debridement and herbal-mineral antimicrobial care
  • Provides cross-cultural utilization signal for Ayurvedic CAM management of DFU complications

Limitaciones

  • Single case (n=1) - cannot establish efficacy
  • Highly multimodal intervention precludes attribution to leech therapy alone
  • No randomized comparator versus standard amputation pathway
  • Long-term durability of healing and recurrence rates not reported
  • Selection bias - successful Ayurveda case reports tend to be over-represented in CAM literature

Implicaciones clínicas

Bopparathi 2023 documents that integrated Ayurvedic management including medicinal leech therapy may achieve limb salvage in DFU with osteomyelitis where conventional care had failed. For US clinicians, the case does not support routine adoption — the multimodal Ayurvedic intervention is not the standard US wound-care pathway and direct comparison to standard surgical care is not available. The trial is included in the registry to document the cross-cultural utilization of leech therapy as an adjunct in limb-salvage strategies for complex DFU. It complements the Nayak 2008 diabetic-foot RCT and the Zaidi 2014 Unani DFU case in framing the global Ayurveda/Unani CAM landscape for DFU management.

Estudios relacionados

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.